Literature DB >> 3257017

Preferences and asymmetries in saccadic responses to delayed bihemifield stimuli.

Y Y Zeevi1, P A Wetzel, G A Geri.   

Abstract

Saccaadic response preferences and latencies were measured using dual targets presented at 5, 10 and 15 deg along the horizontal meridian in either one or both visual hemifields. In the unihemifield condition, subjects exhibited a strong preference (about 95%) in favor of the target presented closer to the original fixation point. Further, the presence of the second target did not increase the response latency to the preferred target. In the bihemifield condition using spatially symmetric targets, directional preference varied across subjects from 57 to 100% (mean = 83%). There was also a significant increase in response latency as compared with responses to either single targets or dual targets presented in one hemifield. This latency increase was observed for responses in both the preferred and nonpreferred directions and was taken as evidence of mutual interaction between the two hemispheres. The response preferences could be eliminated by delaying the onset of the preferred target by about 100 msec in the unihemifield condition and by about 50 msec in the bihemifield condition. Further, the interactions between the effects of the targets on response time in the bihemifield condition were found to be asymmetrical in that a target presented in the preferred hemifield has a greater effect than a target in the nonpreferred hemifield on responses to targets presented in the counterhemifield. The results suggest an asymmetry in hemispheric interaction which has not previously been demonstrated in the visualoculomotor system.

Mesh:

Year:  1988        PMID: 3257017     DOI: 10.1016/0042-6989(88)90141-1

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  1 in total

1.  Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.

Authors:  Mónica López-Guerra; Sílvia Xargay-Torrent; Patricia Fuentes; Jocabed Roldán; Blanca González-Farré; Laia Rosich; Elisabeth Silkenstedt; María J García-León; Eriong Lee-Vergés; Neus Giménez; Ariadna Giró; Marta Aymerich; Neus Villamor; Julio Delgado; Armando López-Guillermo; Xose S Puente; Elias Campo; María L Toribio; Dolors Colomer
Journal:  Oncogene       Date:  2019-10-15       Impact factor: 9.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.